Optimal dose range of epidural naloxone to reduce nausea in patients receiving epidural morphine.
Kim
Eun Sung
ES
Lee
Jaemin
J
Choi
Jong Ho
JH
D015360:Analgesia, Epidural / Q000379:methods*; D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D000768:Anesthesia, General / Q000379:methods; D000779:Anesthetics, Local / Q000627:therapeutic use; D002045:Bupivacaine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D009020:Morphine / Q000009:adverse effects* / Q000627:therapeutic use; D009270:Naloxone / Q000008:administration & dosage / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D010147:Pain Measurement; D020250:Postoperative Nausea and Vomiting / Q000139:chemically induced / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D002045:Bupivacaine